1. Home
  2. NYMTL vs ZLAB Comparison

NYMTL vs ZLAB Comparison

Compare NYMTL & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYMTL
  • ZLAB
  • Stock Information
  • Founded
  • NYMTL N/A
  • ZLAB 2013
  • Country
  • NYMTL United States
  • ZLAB China
  • Employees
  • NYMTL 79
  • ZLAB N/A
  • Industry
  • NYMTL Real Estate Investment Trusts
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NYMTL Real Estate
  • ZLAB Health Care
  • Exchange
  • NYMTL Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • NYMTL N/A
  • ZLAB 3.5B
  • IPO Year
  • NYMTL N/A
  • ZLAB 2017
  • Fundamental
  • Price
  • NYMTL $22.00
  • ZLAB $29.24
  • Analyst Decision
  • NYMTL
  • ZLAB Buy
  • Analyst Count
  • NYMTL 0
  • ZLAB 4
  • Target Price
  • NYMTL N/A
  • ZLAB $47.37
  • AVG Volume (30 Days)
  • NYMTL N/A
  • ZLAB 1.2M
  • Earning Date
  • NYMTL N/A
  • ZLAB 05-08-2025
  • Dividend Yield
  • NYMTL N/A
  • ZLAB N/A
  • EPS Growth
  • NYMTL N/A
  • ZLAB N/A
  • EPS
  • NYMTL N/A
  • ZLAB N/A
  • Revenue
  • NYMTL N/A
  • ZLAB $418,326,000.00
  • Revenue This Year
  • NYMTL N/A
  • ZLAB $44.43
  • Revenue Next Year
  • NYMTL N/A
  • ZLAB $48.68
  • P/E Ratio
  • NYMTL N/A
  • ZLAB N/A
  • Revenue Growth
  • NYMTL N/A
  • ZLAB 43.72
  • 52 Week Low
  • NYMTL N/A
  • ZLAB $15.65
  • 52 Week High
  • NYMTL N/A
  • ZLAB $39.77
  • Technical
  • Relative Strength Index (RSI)
  • NYMTL 65.50
  • ZLAB 42.71
  • Support Level
  • NYMTL $21.16
  • ZLAB $27.61
  • Resistance Level
  • NYMTL $21.93
  • ZLAB $32.02
  • Average True Range (ATR)
  • NYMTL 0.28
  • ZLAB 1.23
  • MACD
  • NYMTL 0.12
  • ZLAB -0.18
  • Stochastic Oscillator
  • NYMTL 100.00
  • ZLAB 23.41

About NYMTL New York Mortgage Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: